Register and share your invite link to earn from video plays and referrals.

Hardik Shah
@AIStockSavvy
Breaking US stock news, earnings & analyst calls, AI-powered | Trade on facts, not hype | Turn on 🔔 so you never miss a move | NFA
Joined September 2009
1.2K Following    43.6K Followers
đŸ“ĸ 𝗝𝗨đ—Ļ𝗧 𝗜𝗡: Anthropic Partners With Six Life Sciences Firms to Accelerate AI-Powered Drug Development - $ANT $BMY 👉 𝗞𝗲𝘆 𝗛đ—ļ𝗴đ—ĩ𝗹đ—ļ𝗴đ—ĩ𝘁𝘀: ➤ 𝗔đ—ģ𝘁đ—ĩđ—ŋđ—ŧđ—Ŋđ—ļ𝗰 partners with 𝟲 𝗹đ—ļđ—ŗđ—˛ 𝘀𝗰đ—ļ𝗲đ—ģ𝗰𝗲𝘀 organizations to test Claude. ➤ Partners include 𝗕đ—ŋđ—ļ𝘀𝘁đ—ŧ𝗹 𝗠𝘆𝗲đ—ŋ𝘀 đ—Ļ𝗾𝘂đ—ļđ—¯đ—¯, 𝗕đ—ļ𝗴𝗛𝗮𝘁, 𝗘đ—ģ𝘃𝗲𝗱𝗮, 𝗗đ—ļ𝘃𝗲đ—ŋ𝗴𝗲đ—ģ𝗰𝗲, 𝗚𝗲đ—ģ𝗲đ—ŋ𝗮𝘁𝗲, and 𝗧đ—ĩ𝗲 𝗖đ—ŧ𝗹𝘂đ—ēđ—ģ 𝗚đ—ŋđ—ŧ𝘂đ—Ŋ. ➤ 𝗚𝗲đ—ģ𝗲đ—ŋ𝗮𝘁𝗲 𝗕đ—ļđ—ŧđ—ē𝗲𝗱đ—ļ𝗰đ—ļđ—ģ𝗲𝘀 designed a đŸŗđŸŦ% 𝘀đ—ĩđ—ŧđ—ŋ𝘁𝗲đ—ŋ CAR T-cell component using Claude. ➤ Modified design produced approximately 𝟭đŸŦ𝘅 đ—ēđ—ŧđ—ŋ𝗲 cancer-targeting receptors in lab tests. ➤ 𝗗đ—ļ𝘃𝗲đ—ŋ𝗴𝗲đ—ģ𝗰𝗲 đ—Ÿđ—Žđ—¯đ˜€ generated approximately đŸ¯đŸą,đŸŦđŸŦđŸŦ 𝗮đ—ģ𝘁đ—ļđ—¯đ—ŧ𝗱𝘆 𝗱𝗲𝘀đ—ļ𝗴đ—ģ𝘀 in one month. ➤ 𝗘đ—ģ𝘃𝗲𝗱𝗮 used Claude to review 𝟭,đŸŦ𝟲𝟭 đ—Ŋ𝗮𝗴𝗲𝘀 of manufacturing documentation. ➤ Claude identified 𝟭𝟭 𝗸đ—ģđ—ŧ𝘄đ—ģ đ—ļ𝘀𝘀𝘂𝗲𝘀 plus đŸŗ 𝗮𝗱𝗱đ—ļ𝘁đ—ļđ—ŧđ—ģ𝗮𝗹 đ—ļ𝘀𝘀𝘂𝗲𝘀, reducing review time 𝟴đŸĩ%. ➤ Claude drafted a regulatory document in 𝟰 đ—ĩđ—ŧ𝘂đ—ŋ𝘀 versus approximately đŸ¯ đ—ēđ—ŧđ—ģ𝘁đ—ĩ𝘀. ➤ 𝗕đ—ŋđ—ļ𝘀𝘁đ—ŧ𝗹 𝗠𝘆𝗲đ—ŋ𝘀 đ—Ļ𝗾𝘂đ—ļđ—¯đ—¯ uses Claude for clinical trial planning and success estimates. ➤ Anthropic acquired 𝗠đ—ļ𝘁đ—ĩđ—ŋđ—ļ𝗹 𝗠𝗲𝗱đ—ļ𝗰đ—ļđ—ģ𝗲 and launched 𝗖𝗹𝗮𝘂𝗱𝗲 đ—Ļ𝗰đ—ļ𝗲đ—ģ𝗰𝗲. 👉 đ—Ēđ—ĩ𝘆 𝗧đ—ĩđ—ļ𝘀 𝗠𝗮𝘁𝘁𝗲đ—ŋ𝘀: ➤ Demonstrates AI's potential to 𝗮𝗰𝗰𝗲𝗹𝗲đ—ŋ𝗮𝘁𝗲 𝗱đ—ŋ𝘂𝗴 𝗱đ—ļ𝘀𝗰đ—ŧ𝘃𝗲đ—ŋ𝘆 and reduce development costs. ➤ Significant efficiency gains could transform đ—Ŋđ—ĩ𝗮đ—ŋđ—ē𝗮𝗰𝗲𝘂𝘁đ—ļ𝗰𝗮𝗹 đ—ŋ𝗲𝘀𝗲𝗮đ—ŋ𝗰đ—ĩ and regulatory workflows. ➤ Partnerships position 𝗔đ—ģ𝘁đ—ĩđ—ŋđ—ŧđ—Ŋđ—ļ𝗰 to expand into the high-value đ—¯đ—ļđ—ŧ𝘁𝗲𝗰đ—ĩ 𝗔𝗜 market. ➤ 𝗕đ—ŋđ—ļ𝘀𝘁đ—ŧ𝗹 𝗠𝘆𝗲đ—ŋ𝘀 đ—Ļ𝗾𝘂đ—ļđ—¯đ—¯ (𝗕𝗠đ—Ŧ) gains AI-assisted clinical development capabilities. ➤ Early laboratory results remain preliminary and require đ—ŗđ˜‚đ—ŋ𝘁đ—ĩ𝗲đ—ŋ 𝘃𝗮𝗹đ—ļ𝗱𝗮𝘁đ—ļđ—ŧđ—ģ before clinical use. 👉 𝗘𝘅đ—Ŋ𝗲đ—ŋ𝘁 đ—Ļ𝘁𝗮𝘁𝗲đ—ē𝗲đ—ģ𝘁: 𝗠đ—ļ𝗰đ—ĩ𝗮𝗲𝗹 đ—Ŗđ—ŧ𝘂đ—ŋ𝗱𝗲đ—ĩđ—ģ𝗮𝗱, Senior Vice President and Head of Early Clinical Development at Bristol Myers Squibb: "generated a robust initial analysis that helped inform our assessment of different development options, which would otherwise take days to complete."
Show more